Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Amivantamab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Portland, Oregon
This trial will study the effectiveness of a new cancer treatment, given as a shot under the skin, in combination with another existing cancer treatment. The safety of the new treatment will also be studied.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.